Sept 15, 2026

Interested in the full white paper?

Submit the access request form below. Once your request has been received, we will send you a link to access the complete white paper.

Access Request

Please complete the short form below to request access to this resource.

We will use your information to process your request and provide the requested materials.

Minicircle DNA for LNP-based delivery

Explore the role of DNA format in non-viral delivery

Lipid nanoparticles have become an important platform for nucleic acid delivery. As new applications move beyond mRNA, the properties of the DNA cargo itself become increasingly relevant.

This white paper takes a closer look at Minicircle DNA as a compact, bacterial-backbone-free DNA format for LNP-based delivery. It discusses the characteristics that distinguish Minicircle DNA from conventional plasmid DNA and the considerations that may become relevant when combining DNA cargo with lipid nanoparticle systems.

In this white paper you will learn more about:

  • the characteristics of Minicircle DNA relevant to LNP-based delivery
  • how DNA size and composition can affect the design of non-viral delivery approaches
  • current considerations and potential applications for combining Minicircle DNA with LNP technologies

Whether you are evaluating non-viral delivery strategies, developing DNA-based therapeutics or exploring alternative nucleic acid formats, the white paper provides a technical introduction to the topic and the questions worth considering during development.

Further events